Company / PP&E (Net)
SELLAS Life Sciences Group, Inc. PP&E (Net) History
FY2015-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$199.0K
FY2016
5-year range
-
FY2015-FY2016
Trend
-40.6%
vs FY2015
Sector context
#178 of 193
Health Care
What the data says
Among 193 Health Care companies, SELLAS Life Sciences Group, Inc. is in the bottom 8% for pp&e (net).
Based on SEC 10-K filings.
$199,000 in FY2016.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 193This company $199.0K Sector average $777.6M
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2016, pp&e (net) decreased 40.6% year-over-year.
- Ranks #178 out of 193 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $199.0K | -40.6% |
| FY2015 | $335.0K | +17.5% |
As of FY2016 · SEC 10-K · Updated Jun 30, 2026